This Gal-3 inhibitor induces apoptosis in multiple myeloma cells including resistant myeloma cells to Doxorubicin, Melfalan, Dexamethason [92] and Bortezomib [105] (Table 3). Here, LGALS3 is linked to plasma cell myeloma.